GlobalData on MSN

Lipocine completes Phase III enrolment for LPCN 1154 in PPD

Lipocine has announced the completion of enrolment and participant dosing in its Phase III clinical trial investigating LPCN ...

Reunion Neuroscience Presents Full Data from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) at ACNP Annual Meeting

RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...